NOXXON Pharma N.V. announced the appointment of four leading pancreatic cancer experts to its Scientific Advisory Board (SAB). Led by the newly appointed Chair, Dr. Jose Saro, the SAB will provide strategic and scientific counsel to NOXXON’s clinical programs in this indication. The members of NOXXON’s SAB for pancreatic cancer are listed below. Chiorean, E. Gabriela, MD. O’Reilly, Eileen M., MD. Prof. Dr. Seufferlein, Thomas T. W. Von Hoff, Daniel D.,MD, FACP, FASCO, FAACR.